Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001736730-25-000086
Filing Date
2025-11-03
Accepted
2025-11-03 16:16:04
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-3 camp4therapeutics-sx3.htm S-3 295349
2 camp4110325exfilingfees.htm   iXBRL EX-FILING FEES 26075
3 EX-5.1 exhibit51-sx3.htm EX-5.1 12908
4 EX-23.2 exhibit232-sx3.htm EX-23.2 2230
5 ropesgraylogo.jpg GRAPHIC 31005
  Complete submission text file 0001736730-25-000086.txt   503792

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT camp4110325exfilingfees_htm.xml XML 5453
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-291225 | Film No.: 251444302
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)